Vorinostat Recruiting Phase 2 Trials for Refractory Epilepsy Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03894826Voronistat in Pediatric Patients With Drug Resistant Epilepsy